{"id":"https://openalex.org/W2001997346","doi":"https://doi.org/10.4088/pcc.12m01494","title":"Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder","display_name":"Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder","publication_year":2013,"publication_date":"2013-06-20","ids":{"openalex":"https://openalex.org/W2001997346","doi":"https://doi.org/10.4088/pcc.12m01494","mag":"2001997346","pmid":"https://pubmed.ncbi.nlm.nih.gov/24171147","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3795584"},"language":"en","primary_location":{"id":"doi:10.4088/pcc.12m01494","doi":"https://doi.org/10.4088/pcc.12m01494","is_oa":true,"landing_page_url":"https://doi.org/10.4088/pcc.12m01494","pdf_url":"https://www.psychiatrist.com/read-pdf/25594","source":{"id":"https://openalex.org/S4210179967","display_name":"The Primary Care Companion For CNS Disorders","issn_l":"2155-7772","issn":["2155-7772","2155-7780"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Primary Care Companion For CNS Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.psychiatrist.com/read-pdf/25594","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079329164","display_name":"Susan L. McElroy","orcid":"https://orcid.org/0000-0002-8879-0865","observed_orcids":["https://orcid.org/0000-0002-8879-0865"]},"institutions":[{"id":"https://openalex.org/I4210121234","display_name":"Lindner Center of HOPE","ror":"https://ror.org/01xv43c68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210121234"]},{"id":"https://openalex.org/I4405272581","display_name":"Orexigen Therapeutics (United States)","ror":"https://ror.org/04cnvsy93","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272581"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Susan L. McElroy","raw_affiliation_strings":["Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","institution_ids":["https://openalex.org/I4210121234","https://openalex.org/I4405272581","https://openalex.org/I63135867"]},{"raw_affiliation_string":"Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy)","institution_ids":["https://openalex.org/I4210121234"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086501238","display_name":"Anna I. Guerdjikova","orcid":"https://orcid.org/0000-0002-8141-0698","observed_orcids":["https://orcid.org/0000-0002-8141-0698"]},"institutions":[{"id":"https://openalex.org/I4210121234","display_name":"Lindner Center of HOPE","ror":"https://ror.org/01xv43c68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210121234"]},{"id":"https://openalex.org/I4405272581","display_name":"Orexigen Therapeutics (United States)","ror":"https://ror.org/04cnvsy93","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272581"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna I. Guerdjikova","raw_affiliation_strings":["Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","institution_ids":["https://openalex.org/I4210121234","https://openalex.org/I4405272581","https://openalex.org/I63135867"]},{"raw_affiliation_string":"Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova)","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084708084","display_name":"Dennis Dong Hwan Kim","orcid":"https://orcid.org/0000-0003-2640-4911","observed_orcids":["https://orcid.org/0000-0003-2640-4911","https://orcid.org/0000-0002-0708-9242","https://orcid.org/0000-0002-0998-1090"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]},{"id":"https://openalex.org/I4210121234","display_name":"Lindner Center of HOPE","ror":"https://ror.org/01xv43c68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210121234"]},{"id":"https://openalex.org/I4405272581","display_name":"Orexigen Therapeutics (United States)","ror":"https://ror.org/04cnvsy93","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272581"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis D. Kim","raw_affiliation_strings":["Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","Amgen (United States), Thousand Oaks, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","institution_ids":["https://openalex.org/I4210121234","https://openalex.org/I4405272581","https://openalex.org/I63135867"]},{"raw_affiliation_string":"Amgen (United States), Thousand Oaks, United States","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029508815","display_name":"Colleen M. Burns","orcid":"https://orcid.org/0000-0002-2646-4300","observed_orcids":["https://orcid.org/0000-0002-2646-4300"]},"institutions":[{"id":"https://openalex.org/I4210121234","display_name":"Lindner Center of HOPE","ror":"https://ror.org/01xv43c68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210121234"]},{"id":"https://openalex.org/I4405272581","display_name":"Orexigen Therapeutics (United States)","ror":"https://ror.org/04cnvsy93","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272581"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen Burns","raw_affiliation_strings":["Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","Lindner Center of HOPE, 4075 Old Western Row Rd, Mason, OH 45040","Research Institute,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","institution_ids":["https://openalex.org/I4210121234","https://openalex.org/I4405272581","https://openalex.org/I63135867"]},{"raw_affiliation_string":"Lindner Center of HOPE, 4075 Old Western Row Rd, Mason, OH 45040","institution_ids":["https://openalex.org/I4210121234"]},{"raw_affiliation_string":"Research Institute,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044358533","display_name":"Ra\u00fal Harris-Collazo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121234","display_name":"Lindner Center of HOPE","ror":"https://ror.org/01xv43c68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210121234"]},{"id":"https://openalex.org/I4405272581","display_name":"Orexigen Therapeutics (United States)","ror":"https://ror.org/04cnvsy93","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272581"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ra\u00fal Harris-Collazo","raw_affiliation_strings":["Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","Lindner Center of HOPE, 4075 Old Western Row Rd, Mason, OH 45040","Research Institute,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","institution_ids":["https://openalex.org/I4210121234","https://openalex.org/I4405272581","https://openalex.org/I63135867"]},{"raw_affiliation_string":"Lindner Center of HOPE, 4075 Old Western Row Rd, Mason, OH 45040","institution_ids":["https://openalex.org/I4210121234"]},{"raw_affiliation_string":"Research Institute,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112760532","display_name":"Ronald P. Landbloom","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121234","display_name":"Lindner Center of HOPE","ror":"https://ror.org/01xv43c68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210121234"]},{"id":"https://openalex.org/I4405272581","display_name":"Orexigen Therapeutics (United States)","ror":"https://ror.org/04cnvsy93","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272581"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald Landbloom","raw_affiliation_strings":["Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","Lindner Center of HOPE, 4075 Old Western Row Rd, Mason, OH 45040","Research Institute,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","institution_ids":["https://openalex.org/I4210121234","https://openalex.org/I4405272581","https://openalex.org/I63135867"]},{"raw_affiliation_string":"Lindner Center of HOPE, 4075 Old Western Row Rd, Mason, OH 45040","institution_ids":["https://openalex.org/I4210121234"]},{"raw_affiliation_string":"Research Institute,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001714341","display_name":"Eduardo Dunayevich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121234","display_name":"Lindner Center of HOPE","ror":"https://ror.org/01xv43c68","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210121234"]},{"id":"https://openalex.org/I4405272581","display_name":"Orexigen Therapeutics (United States)","ror":"https://ror.org/04cnvsy93","country_code":"US","type":"company","lineage":["https://openalex.org/I4405272581"]},{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eduardo Dunayevich","raw_affiliation_strings":["Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","Lindner Center of HOPE, 4075 Old Western Row Rd, Mason, OH 45040","Research Institute,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Institute, Lindner Center of HOPE, Mason, Ohio (Dr McElroy); Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio (Drs McElroy and Guerdjikova); and Orexigen Therapeutics, Inc, La Jolla, California (Drs Burns, Kim, Harris-Collazo, Landbloom, and Dunayevich). Dr Kim is currently employed by Zafgen. Dr Harris-Collazo is currently employed by Santarus. Dr Landbloom is currently employed by Merck. Dr Dunayevich is currently employed by Amgen","institution_ids":["https://openalex.org/I4210121234","https://openalex.org/I4405272581","https://openalex.org/I63135867"]},{"raw_affiliation_string":"Lindner Center of HOPE, 4075 Old Western Row Rd, Mason, OH 45040","institution_ids":["https://openalex.org/I4210121234"]},{"raw_affiliation_string":"Research Institute,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5079329164"],"corresponding_institution_ids":["https://openalex.org/I4210121234","https://openalex.org/I4405272581","https://openalex.org/I63135867"],"apc_list":null,"apc_paid":null,"fwci":2.5795,"has_fulltext":true,"cited_by_count":40,"citation_normalized_percentile":{"value":0.87351234,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"15","issue":"3","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.01720000058412552,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10263","display_name":"Eating Disorders and Behaviors","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.8650000095367432},{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.9990000128746033},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.8069999814033508},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8820000290870667},{"id":"https://openalex.org/keywords/overweight","display_name":"overweight","score":0.9739999771118164},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7429999709129333},{"id":"https://openalex.org/keywords/combination-pharmacotherapy","display_name":"combination pharmacotherapy","score":0.6579999923706055},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.550000011920929},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5619999766349792},{"id":"https://openalex.org/keywords/women","display_name":"women","score":0.3840000033378601},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.5429999828338623},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7210000157356262},{"id":"https://openalex.org/keywords/antidepressant-induced-weight-gain","display_name":"antidepressant-induced weight gain","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7503443360328674},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.6773251891136169},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.6628563404083252},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.628630518913269},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6107434630393982},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.5697093605995178},{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.5209137797355652},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5194751620292664},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.4967270493507385},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.49084407091140747},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4502496123313904},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.360950231552124},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.36084485054016113},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2921973466873169},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.06680750846862793},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.4088/pcc.12m01494","doi":"https://doi.org/10.4088/pcc.12m01494","is_oa":true,"landing_page_url":"https://doi.org/10.4088/pcc.12m01494","pdf_url":"https://www.psychiatrist.com/read-pdf/25594","source":{"id":"https://openalex.org/S4210179967","display_name":"The Primary Care Companion For CNS Disorders","issn_l":"2155-7772","issn":["2155-7772","2155-7780"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Primary Care Companion For CNS Disorders","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2797459","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3795584","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:24171147","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24171147","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The primary care companion for CNS disorders","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3795584","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3795584/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prim Care Companion CNS Disord","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.4088/pcc.12m01494","doi":"https://doi.org/10.4088/pcc.12m01494","is_oa":true,"landing_page_url":"https://doi.org/10.4088/pcc.12m01494","pdf_url":"https://www.psychiatrist.com/read-pdf/25594","source":{"id":"https://openalex.org/S4210179967","display_name":"The Primary Care Companion For CNS Disorders","issn_l":"2155-7772","issn":["2155-7772","2155-7780"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Primary Care Companion For CNS Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"},{"id":"https://openalex.org/F4320315147","display_name":"Orexigen Therapeutics","ror":"https://ror.org/04cnvsy93"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2001997346.pdf","grobid_xml":"https://content.openalex.org/works/W2001997346.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1635084872","https://openalex.org/W1966203433","https://openalex.org/W1974339756","https://openalex.org/W1983474740","https://openalex.org/W1997115741","https://openalex.org/W2000053835","https://openalex.org/W2015262080","https://openalex.org/W2019078949","https://openalex.org/W2029164503","https://openalex.org/W2036089668","https://openalex.org/W2046859247","https://openalex.org/W2051180837","https://openalex.org/W2053575156","https://openalex.org/W2058871198","https://openalex.org/W2065728981","https://openalex.org/W2070685985","https://openalex.org/W2073912822","https://openalex.org/W2083453232","https://openalex.org/W2086564524","https://openalex.org/W2099336264","https://openalex.org/W2109755434","https://openalex.org/W2110438413","https://openalex.org/W2112090303","https://openalex.org/W2113572448","https://openalex.org/W2114753910","https://openalex.org/W2118826874","https://openalex.org/W2122522992","https://openalex.org/W2131823335","https://openalex.org/W2137700844","https://openalex.org/W2144589456","https://openalex.org/W2144835023","https://openalex.org/W2152202997","https://openalex.org/W2157000531","https://openalex.org/W2158218002","https://openalex.org/W2162802907","https://openalex.org/W2162856122","https://openalex.org/W2170684975","https://openalex.org/W3090293687","https://openalex.org/W4280624097","https://openalex.org/W6662465761"],"related_works":["https://openalex.org/W7143701294","https://openalex.org/W2755066804","https://openalex.org/W3158657129","https://openalex.org/W1869731080","https://openalex.org/W2089415099","https://openalex.org/W4413535638","https://openalex.org/W2341654874","https://openalex.org/W7030594636","https://openalex.org/W2110438413","https://openalex.org/W2113572448"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,83,243],"effect":[4],"of":[5,34,38,60,214,235,265],"32-mg/d":[6],"naltrexone":[7],"sustained":[8,13],"release":[9,14],"and":[10,18,44,51,67,106,120,148,158,180,189,194,223,252,271,281],"360-mg/d":[11],"bupropion":[12],"(NB32)":[15],"in":[16,82,104,226,278,285],"overweight":[17],"obese":[19],"patients":[20,29,125,215],"with":[21,30,63,65,126,239,254,269,276,288],"major":[22],"depressive":[23,279],"disorder":[24],"(MDD).":[25],"METHOD:":[26],"Twenty-five":[27],"female":[28],"a":[31,45],"DSM-IV":[32],"diagnosis":[33],"MDD,":[35],"an":[36],"Inventory":[37],"Depressive":[39],"Symptomatology-Self-Report":[40],"score":[41,90,99,114,132,220,229],">":[42],"26,":[43],"body":[46,283],"mass":[47],"index":[48],"\u2265":[49,127],"27":[50],"\u2264":[52,115,221],"43":[53],"kg/m(2)":[54],"received":[55],"up":[56],"to":[57,260],"24":[58,121,149,202],"weeks":[59,118,146,264],"open-label":[61,266],"treatment":[62],"NB32":[64,236,267],"dietary":[66,270],"behavioral":[68,272],"counseling":[69,273],"(data":[70],"collection:":[71],"March":[72],"2008-July":[73],"2009).":[74],"The":[75,232],"primary":[76],"endpoint":[77],"was":[78,175,237,274],"change":[79,103],"from":[80],"baseline":[81,167,207],"Montgomery-Asberg":[84],"Depression":[85],"Rating":[86],"Scale":[87],"(MADRS)":[88],"total":[89,98,131],"at":[91,100,117,145,186,200],"12":[92,119,147,188],"weeks;":[93],"secondary":[94],"endpoints":[95],"included":[96],"MADRS":[97,130,140],"week":[101,187,201,211],"24,":[102,212],"weight,":[105],"Clinical":[107],"Global":[108],"Impressions-Improvement":[109],"scale":[110],"responder":[111],"status":[112],"(CGI-I":[113,219,228],"2)":[116,222],"(modified":[122],"intent-to-treat":[123],"[mITT]:":[124],"1":[128],"postbaseline":[129],"on":[133],"study":[134],"drug;":[135],"N":[136],"=":[137,230],"23).":[138],"RESULTS:":[139],"scores":[141],"showed":[142],"significant":[143],"reductions":[144],"(mITT-last":[150],"observation":[151],"carried":[152],"forward":[153],"[LOCF]:":[154],"-13.1":[155],"\u00b1":[156,160,171,177,182,191,196],"7.1":[157],"-15.3":[159],"8.1,":[161],"respectively,":[162],"P":[163],"<":[164,204],".001":[165,205],"vs":[166,206],"for":[168,208],"all).":[169,209],"Mean":[170],"SD":[172],"weight":[173,284],"loss":[174],"-4.0%":[176],"4.6%":[178],"(mITT-LOCF)":[179,193,216],"-6.1%":[181],"4.7%":[183],"(observed":[184,198],"cases)":[185,199],"-5.3%":[190],"6.5%":[192],"-9.2%":[195],"6.2%":[197],"(P":[203],"By":[210],"95%":[213],"were":[217,225,248],"responders":[218],"70%":[224],"remission":[227],"1).":[231],"safety/tolerability":[233],"profile":[234],"consistent":[238],"its":[240],"individual":[241],"components;":[242],"most":[244],"common":[245],"adverse":[246,257],"events":[247,258],"nausea,":[249],"constipation,":[250],"headache,":[251],"insomnia,":[253],"no":[255],"serious":[256],"attributed":[259],"NB32.":[261],"CONCLUSION:":[262],"Twenty-four":[263],"therapy":[268],"associated":[275],"improvement":[277],"symptoms":[280],"reduced":[282],"overweight/obese":[286],"women":[287],"MDD.":[289],"TRIAL":[290],"REGISTRATION:":[291],"ClinicalTrials.gov":[292],"Identifier:":[293],"NCT00624858.":[294]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}